Scarica l'app Stockscreener
44.06
2.59%
-1.17
Pre-mercato:
44.37
0.31
+0.70%
Precedente Chiudi:
$45.23
Aprire:
$45.04
Volume 24 ore:
931.46K
Relative Volume:
1.12
Capitalizzazione di mercato:
$1.92B
Reddito:
$1.24B
Utile/perdita netta:
$23.68M
Rapporto P/E:
104.90
EPS:
0.42
Flusso di cassa netto:
$108.67M
1 W Prestazione:
+25.31%
1M Prestazione:
+29.74%
6M Prestazione:
-17.77%
1 anno Prestazione:
-27.94%
Intervallo 1D:
$44.03
$45.19
Intervallo di 1 settimana:
$39.36
$45.77
Portata 52W:
$32.48
$63.57
Livanova Plc Stock (LIVN) Company Profile
Nome
Livanova Plc
Settore
Industria
Telefono
4402033250662
Indirizzo
20 EASTBOURNE TERRACE, LONDON
Confronta LIVN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
44.06 | 1.92B | 1.24B | 23.68M | 108.67M | 0.42 |
|
ABT
Abbott Laboratories
|
129.05 | 231.50B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.95 | 154.04B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.53 | 144.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.11 | 105.58B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.50 | 43.95B | 5.54B | 4.18B | 623.10M | 7.00 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | Iniziato | Goldman | Buy |
| 2024-09-17 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | Reiterato | Needham | Buy |
| 2024-02-20 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-09-06 | Iniziato | HSBC Securities | Hold |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2023-04-14 | Iniziato | Mizuho | Neutral |
| 2022-12-21 | Iniziato | Barclays | Equal Weight |
| 2022-04-06 | Iniziato | Wolfe Research | Outperform |
| 2022-02-24 | Aggiornamento | UBS | Neutral → Buy |
| 2021-12-03 | Iniziato | Goldman | Buy |
| 2021-08-20 | Reiterato | Needham | Buy |
| 2021-07-20 | Aggiornamento | Needham | Hold → Buy |
| 2021-03-03 | Downgrade | Berenberg | Buy → Hold |
| 2021-01-05 | Downgrade | Needham | Buy → Hold |
| 2020-09-02 | Iniziato | Robert W. Baird | Outperform |
| 2020-06-26 | Reiterato | Needham | Buy |
| 2019-10-30 | Reiterato | Needham | Buy |
| 2019-02-28 | Reiterato | Needham | Buy |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-06-08 | Iniziato | Stifel | Buy |
| 2018-05-31 | Reiterato | Needham | Buy |
| 2018-02-28 | Reiterato | Needham | Buy |
Mostra tutto
Livanova Plc Borsa (LIVN) Ultime notizie
LIVN Stock Rating Reiterated at 'Buy' by Needham Analyst | LIVN - GuruFocus
LivaNova PLC (NASDAQ:LIVN) Q1 2025 Earnings Call Transcript - Insider Monkey
How to Take Advantage of moves in (LIVN) - news.stocktradersdaily.com
LivaNova PLC: Strong Growth Amidst Challenges in Earnings Call - TipRanks
Electroceuticals Market Top PlayersMedtronic Plc (Ireland), - openPR.com
Vagus Nerve Stimulators Market Is Booming Worldwide | LivaNova - openPR.com
New Trial Reveals Sustained Benefits for Investigational Sleep Apnea Neurostimulator - Sleep Review
Jefferies lifts Livanova stock price target to $79 from $74 - Investing.com Australia
LivaNova (LIVN) Receives Price Target Boost from Baird | LIVN Stock News - GuruFocus
LivaNova Q1 2025 revenue increases 7.4% to USD 316.9M - Medical Buyer
Barclays Adjusts LivaNova (LIVN) Price Target Amid Strong Performance | LIVN Stock News - GuruFocus
LivaNova PLC (LIVN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advances - Yahoo Finance
LivaNova PLC Reports Strong Q1 2025 Results - TipRanks
Jefferies lifts Livanova stock price target to $79 from $74 By Investing.com - Investing.com South Africa
LivaNova: Q1 Earnings Snapshot - MySA
LivaNova PLC earnings beat by $0.12, revenue topped estimates - Investing.com Nigeria
LivaNova PLC SEC 10-Q Report - TradingView
Are LivaNova PLC's (NASDAQ:LIVN) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? - Yahoo Finance
LivaNova Q1 2025 Earnings Call Transcript - MarketBeat
Will LivaNova's Growth And Innovation Drive Sustained Gains In 2025? - Nasdaq
LivaNova submits nerve stim for sleep apnea to FDA, raises 2025 guidance - MassDevice
LivaNova Q1 Adjusted Earnings, Net Revenue Rise; 2025 Outlook Revised - marketscreener.com
LivaNova PLC Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance
LIVN Surpasses Q1 Revenue Expectations with Robust Growth | LIVN Stock News - GuruFocus
LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance - BioSpace
LivaNova PLC Q1 2025 Earnings: Revenue Hits $316.9M, Adjusted EPS Soars to $0.88, Both Surpass Estimates - GuruFocus
LIVN Reports Promising 12-Month Results from OSPREY Sleep Apnea Trial | LIVN Stock News - GuruFocus
LivaNova plc (LIVN) Tops Q1 EPS by 12c ; Offers Guidance - StreetInsider
Earnings Flash (LIVN) LIVANOVA PLC Reports Q1 Revenue $316.9M, vs. FactSet Est of $302.4M - marketscreener.com
LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy | LIVN Stock News - GuruFocus
LivaNova Announces 12-Month Data From Osprey Clinical Study For Moderate To Severe Obstructive Sleep Apnea, Demonstrating Strong Response And Durability Of Therapy - marketscreener.com
LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy - Business Wire
Should Weakness in LivaNova PLC's (NASDAQ:LIVN) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - simplywall.st
How the (LIVN) price action is used to our Advantage - news.stocktradersdaily.com
Medical Implants Market Projected To Witness Substantial - openPR.com
Is LivaNova PLC (LIVN) the Best Undervalued UK Stock to Buy Right Now? - Insider Monkey
Vagus Nerve Stimulators Market Set to Witness Significant - openPR.com
Mizuho Adjusts Price Target for LivaNova (LIVN) Ahead of Q1 Prev - GuruFocus
What Is LivaNova PLC's (NASDAQ:LIVN) Share Price Doing? - Yahoo Finance
LivaNova PLC (LIVN): Among the Best UK Stocks to Buy According to Billionaires - Insider Monkey
Cardiovascular Devices Market Demand, Growth and Future Scope - openPR.com
Vagus Nerve Stimulators Market Deep Research Report with - openPR.com
With LivaNova PLC (NASDAQ:LIVN) It Looks Like You'll Get What You Pay For - simplywall.st
Aortic Stenosis Market to Witness Massive Growth by 2032 | - openPR.com
10 Best UK Stocks to Buy According to Billionaires - Insider Monkey
Livanova Plc Azioni (LIVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
0.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):